Tonix Pharmaceuticals to Participate in Fourth Annual Neuroscience Innovation Forum
CHATHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage...
Day: April 21, 2021
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial diseases
Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial diseases Study will examine the...
Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Company Exceeds Target Enrollment in Less Than Six Weeks; Data Readout Expected by End of 2021LOS ALTOS, Calif., April 21,...
Revolution Medicines Announces Dosing of First Patient in Phase 1/1b Clinical Study of RMC-5552 in Patients with Advanced Solid Tumors
First-in-Class Bi-steric mTORC1 Inhibitor Advances into Clinical Development Newly Issued U.S. Patent Further Strengthens RMC-5552 IP Portfolio REDWOOD CITY, Calif.,...
Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica
MONTEGO BAY, Jamaica, April 21, 2021 (GLOBE NEWSWIRE) -- Silo Wellness Inc. (“Silo Wellness” or “the Company”) (CSE: SILO) (FRA:3K70),...
TG Therapeutics Announces Launch of the ULTRA-V Phase 3 Trial Evaluating the Triple Combination of UKONIQ™ (umbralisib), Ublituximab, and Venetoclax
ULTRA-V Phase 2 trial has reached completion of patient enrollmentNEW YORK, April 21, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:...
Lord Jones™ Debuts “A Higher Order”
Lord Jones™ is proud to unveil its first-ever brand campaign and new website The Lord Jones campaign assets pique the imagination...
Jushi Holdings Inc. Announces a Delay in Filing 2020 Annual Financial Statements and Related Management’s Discussion and Analysis
Expects to file the 2020 Annual Financial Statements and Related Management’s Discussion and Analysis on or before May 24, 2021...
Trevena Announces TRV027 Selected for Study in Global REMAP-CAP Trial in COVID-19 Patients
-- REMAP-CAP is led by experts in pandemic response and builds upon a worldwide clinical trial network evaluating treatments for...
Embark Delta Inc. Unveils Next Generation of 2.0 Brands and Products Leveraging Proprietary Embark Nano Technology
Toronto, Ontario--(Newsfile Corp. - April 21, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
Immunicom Recognized as One of the Best Places to Work in the U.S.
Breakthrough Immunotherapy Company earns 2021 Great Place to Work Certification™ SAN DIEGO--(BUSINESS WIRE)--#biotech--Immunicom, Inc., a pioneering global biotechnology company, today...
XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test
VANCOUVER, BC / ACCESSWIRE / April 21, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the...